Menotti S. et al. The partial response to first generation somatostatin analogues guides the choice and may predict the outcome of second line therapies with pasireotide lar: data from a real life experience
Menotti S. et al. The partial response to first generation somatostatin analogues guides the choice and may predict the outcome of second line therapies with pasireotide lar: data from a real life experience
